Clicky

ATRYS HEALTH S.A. EO-01(A2T)

Description: Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests. It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.


Keywords: Medicine Medical Imaging Oncology Immunotherapy Telemedicine Chemotherapy Telehealth Medical Physics Radiology Assistive Technology Radiation Therapy Diagnostic Services Radiotherapy Medical Diagnosis Teleradiology Telemedicine Services Brachytherapy Counselling Diagnostics Services Teleophthalmology

Home Page: www.atryshealth.com

Príncipe de Vergara 132
Madrid, 28002
Spain
Phone: 34 917 819 465


Officers

Name Title
Mr. Santiago De Torres Sanahuja Executive Chairman
Ms. Isabel Lozano Fernandez CEO & Executive Director
Dr. Carlos Cordon-Cardo Founder & Scientific Vice President
Dr. Zvi Fuchs Founder and Medical Vice President
Mr. Jose Maria Huch Ginesta Chief Financial Officer
Luis Duran Global Chief Technology Officer
Encarna Vega Administration Director
Ms. Maria Marin Head of Investor Relations
Ms. Gabriela Camunas General Counsel
Pedro Salord People Director

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.8119
Price-to-Sales TTM: 1.1042
IPO Date:
Fiscal Year End: December
Full Time Employees: 2084
Back to stocks